Total submissions: 24
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000170241 | SCV002569941 | pathogenic | Rett syndrome | 2022-07-28 | reviewed by expert panel | curation | The c.925C>T p.(Arg309Trp) variant in MECP2 (NM_004992.3) is absent from gnomAD (PM2_supporting). The p.(Arg309Trp) variant has been observed in at least 5 individuals, including males, with variable neurodevelopmental phenotypes consistent with MECP2-related disease (PMID 26936630, 29655203, 29720203, 28837158, 31178897, 30536762, 32214227) (PS4, PP4). One of the reported individuals with this variant was also found to be heterozygous for a de novo (biological parentage confirmed) SMC3 frameshift variant (PMID 31178897). The p.(Arg309Trp) variant has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in at least 3 of these individuals (PMID 31178897, 26936630) (PS2_very strong). Additional family studies have found the p.(Arg309Trp) variant to be maternally inherited in at least 2 cases (PMID 29720203, 26936630), and inherited from an unaffected mosaic parent in at least 1 case (PMID 28837158). Computational prediction analysis tools are inconclusive for this variant. In summary, the c.925C>T p.(Arg309Trp) variant in MECP2 is classified as Pathogenic for MECP2-related disease based on the ACMG/AMP criteria (PS2_very strong, PS4, PM2_supporting, PP4). |
Gene |
RCV000133293 | SCV000190988 | pathogenic | not provided | 2021-10-25 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28027854, 20479760, 21160487, 17084570, 23810759, 26936630, 28089766, 30536762, 29655203, 29720203, 28837158, 31178897, 32214227) |
Genetic Services Laboratory, |
RCV000170241 | SCV000248007 | pathogenic | Rett syndrome | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000133293 | SCV000343620 | likely pathogenic | not provided | 2016-10-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000133293 | SCV000575669 | pathogenic | not provided | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000624661 | SCV000741171 | likely pathogenic | Inborn genetic diseases | 2015-12-14 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000169947 | SCV000807252 | pathogenic | X-linked intellectual disability-psychosis-macroorchidism syndrome | 2017-09-01 | criteria provided, single submitter | clinical testing | This variant has been previously reported as disease-causing and was found four times in our laboratory (in 3 males and 1 female): maternally inherited in a 6-year-old male with global delays, stereotypic hand movements, hypotonia, failure to thrive; de novo in a 3-year-old female with global delays and hypotonia; maternally inherited in a 4-year-old male with gloabal delays, dysmorphisms, short stature, macrocehaly, retractile testis, hypothyroidism; de novo in a 2-year-old male with global delay, hypotonia, epilepsy, relative macrocephaly |
Mayo Clinic Laboratories, |
RCV000170241 | SCV000809080 | likely pathogenic | Rett syndrome | 2018-04-12 | criteria provided, single submitter | clinical testing | |
Biochemistry Laboratory of CDMU, |
RCV000170241 | SCV000899194 | likely pathogenic | Rett syndrome | criteria provided, single submitter | case-control | ||
Department of Genetics, |
RCV000851523 | SCV000994583 | pathogenic | Intellectual disability | 2019-04-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001049007 | SCV001213039 | pathogenic | Severe neonatal-onset encephalopathy with microcephaly | 2023-12-30 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 309 of the MECP2 protein (p.Arg309Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability and/or clinical characteristics of Rett syndrome (PMID: 17084570, 20479760, 21160487, 23810759, 26936630, 29720203, 30536762). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 143749). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MECP2 protein function. For these reasons, this variant has been classified as Pathogenic. |
Genomic Research Center, |
RCV000170241 | SCV001251808 | pathogenic | Rett syndrome | 2020-05-03 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV000133293 | SCV001446400 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Laboratoire Génétique Moléculaire, |
RCV000133293 | SCV001760747 | likely pathogenic | not provided | 2019-10-28 | criteria provided, single submitter | clinical testing | |
Suma Genomics | RCV000169947 | SCV001837627 | likely pathogenic | X-linked intellectual disability-psychosis-macroorchidism syndrome | criteria provided, single submitter | clinical testing | ||
Laboratoire de Génétique Moléculaire, |
RCV000170241 | SCV003836688 | pathogenic | Rett syndrome | 2020-06-02 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000170241 | SCV003932164 | pathogenic | Rett syndrome | 2023-03-02 | criteria provided, single submitter | clinical testing | PS2_Very Strong, PS4, PM2, PP3 |
Institute Of Human Genetics Munich, |
RCV000170241 | SCV004045783 | pathogenic | Rett syndrome | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003984819 | SCV004801240 | pathogenic | Syndromic X-linked intellectual disability Lubs type | 2024-03-14 | criteria provided, single submitter | research | |
Rett |
RCV000169947 | SCV000188302 | uncertain significance | X-linked intellectual disability-psychosis-macroorchidism syndrome | 2013-12-05 | no assertion criteria provided | curation | |
Rett |
RCV000170240 | SCV000222571 | uncertain significance | Autism, susceptibility to, X-linked 3 | 2013-12-05 | no assertion criteria provided | curation | |
Rett |
RCV000170241 | SCV000222572 | uncertain significance | Rett syndrome | 2013-12-05 | no assertion criteria provided | curation | |
Gene |
RCV000170241 | SCV000998928 | not provided | Rett syndrome | no assertion provided | literature only | ||
Section for Clinical Neurogenetics, |
RCV000170241 | SCV001156091 | pathogenic | Rett syndrome | 2019-08-01 | no assertion criteria provided | research |